Ublituxima shows promising results in the new Multiple Sclerosis treatment trials
An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found. Multiple Sclerosis serious disease which causes you to slowly lose control of your body and become less able to move. Those symptoms include loss of vision in an eye, loss of power […]
